We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/10/2016 08:31 | mm's hitting stops.don't panic that was a great rns,we will go back up,gl,joe | joe shone | |
05/10/2016 08:28 | Nothing goes up in a straight line (especially once 'traders' jump onto the bandwagon.) With the recent volume we might well get some holding RNS's and from the event that's on today/tomorrow. RDZ news this month, so lots to drive it further. Edit: Some traders on Nasdaq went short at $18/$19 down to $14 (£2.20 on AIM) where we will see them close and a Bounce? | waterloo01 | |
05/10/2016 08:24 | Was hoping a further rise today but the Nasdaq has scuppered that. More news could come at anytime so best to stay put. | joeblogg2 | |
05/10/2016 06:11 | Needham & Company LLC Raises Summit Therapeutics PLC (SMMT) Price Target to $30.00 Posted by Donnie Miller on Oct 4th, 2016 // No Comments Summit Therapeutics PLC logoSummit Therapeutics PLC (NASDAQ:SMMT) had its price objective increased by stock analysts at Needham & Company LLC to $30.00 in a report released on Tuesday. Needham & Company LLC’s price objective suggests a potential upside of 109.06% from the company’s current price. hxxp://baseballnewss | h2owater | |
04/10/2016 22:27 | H.Al. So glad your pension is looking rosie now,,good luck pal...also gla lth's | abergele | |
04/10/2016 21:18 | American w/nkers! Will still gap up we lead 🤒 | glenkaz | |
04/10/2016 21:03 | Really volatile finish over in the US. All over the place in last few minutes. Now somewhat below our finish of 2.62. Around 2.24 acc to my calcs. | luminoso | |
04/10/2016 20:16 | Another wainwright note upgrading their price target would be nice. | luminoso | |
04/10/2016 19:15 | Tightfist ... taking that notion to it's conclusion, one might suggest Sarepta's CEO could be renting the apartment on the ground floor in order to try the place out, and without the expense of buying the whole building, he's waiting to see how the final structure comes together before he makes up his mind ... for the moment all we have is a sitting tenant whose helping with some expenses. This is all so intriguing. Whatever the outcome, the guy has certainly paid for the mains water and electricity too be plumbed in ... if one day he wants the lot, he'll still have to pay for the building. ;-) | hugus maximus | |
04/10/2016 18:48 | Freedosh, Thanks for that view (post 21412) on Ridinalazole Phase 3 costs coverage. I am intrigued as to why Sarepta have forged a deal with SUMM that excludes US rights for SRPT. (Apart from the price maybe being too high....) do you see other reasons - or do you foresee that as another-deal-another Thanks, tightfist | tightfist | |
04/10/2016 17:57 | Could do with a strong afternoon stateside | the big fella | |
04/10/2016 16:54 | from the other side of the deal | waterloo01 | |
04/10/2016 16:39 | Freedosh et al, congrats on today, patience rewarded...not often days like these come around so enjoy a glass or two and a nice dinner with the Mr/Mrs :) | sportbilly1976 | |
04/10/2016 16:26 | momentum will not stop here! another 25-30% easy tomorrow!!! dyor | miahkaysor | |
04/10/2016 16:25 | Not Ethel but Dinah (What a difference a day makes) | waterloo01 | |
04/10/2016 15:57 | More news flow due later this week on the new formulation and lots of press and community coverage over the next days/weeks. Edit: Over 10m shares (equivalent) traded so far on Nasdaq. That's most/all the free float. No huge short covering as were only about 35k shares short. | waterloo01 | |
04/10/2016 15:56 | Na I'm staying for huuuuuuuuuuuuuuuge gap up 🤑 | glenkaz | |
04/10/2016 15:47 | It's stopped it's momentum get out | stallone10 | |
04/10/2016 15:41 | That should cover it, tightfist but remember we have to pay for the Dificid. | freedosh | |
04/10/2016 15:39 | Freedosh, An amazing deal. In your opinion, is it conceivable that RDZ Phase 3 could fall within the (max) $62m cash-burn over the next 27 months? Cheers, tightfist | tightfist | |
04/10/2016 15:37 | First figure is what I quoted to Waterloo a few weeks back but 20% royalties is more than most would offer. I would suggest 12%, sorrento | freedosh | |
04/10/2016 15:36 | So up another 20% tomorrow? | sorrento06 | |
04/10/2016 15:34 | Freedosh, how does 200m and 20% sound? | sorrento06 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions